Our latest strategic In Silico presentations have landed!

First presented at the 62nd Annual Society of Toxicology Meeting, the "Implementation of a
Weight of Evidence Carcinogenicity Assessment Aligned with ICH S1B," and "Assessing
-nitrosamine Potency Classes," presentations are now available to watch on demand.

Access Now

Managing SEND Just Got Easier

We are excited to introduce SEND Advantage™ Services. Offering study conversions, compliance services and consulting, our new and refreshed services have been designed to help organizations maintain SEND compliance and more. Watch our on-demand video right now.

Watch Now

Drug Target Review Interviews Instem CSO

Instem CSO, Dr Gordon Baxter, was recently interviewed by Drug Target Review
for an in-depth editorial on Target Safety Assessment.

Download the article

Industry Insights

Join the journey with us by visiting
one of our bi-weekly industry Blogs

Learn More

The future transformed for the benefit of everyone.

Intelligent solutions empowering collaboration and life-enhancing science.

Latest News

Instem Announces Transfer of ToxHub Platform and launch of Centrus®

New powerful technology and data sharing suite provides a range of translational science solutions

Read More

Instem Unveils New Additions to its Leading Computational Toxicology Software Suite

New functionality along with Enhanced Models to Deliver More Efficient and Comprehensive Predictions in Chemical Safety

Read More

Instem Awarded EMA Research Grant

Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines

Read More

Virtual Appointment

Request a quote

Virtual Appointment

To help you better evaluate our software or services, we believe an initial, no pressure Web session is the way to go.

Request a quote

We are excited that you have decided to take the next step with Instem. To provide you with an accurate quotation, we ask that you fill out our form.